Improved glycaemic control in people with type 2 diabetes initiating or switching to <scp>IDegAsp</scp> in a real‐world setting in China
In a broad, real-world Chinese population of adults with T2D, initiating or switching to IDegAsp was associated with improved glycaemic control and lower rates of hypoglycaemia. The use of IDegAsp could be an effective treatment option for those with suboptimal glycaemic control or therapeutic inertia.
Authors
- Fan Zhao (ORCID: https://orcid.org/0000-0002-6633-4316)
- Lixin Guo (ORCID: https://orcid.org/0000-0001-6863-1798)
- Vinay Babu Shankarappa
- Liming Chen (ORCID: https://orcid.org/0000-0002-5682-2340)
- Xing Zhong
- Xiaoyun Liu (ORCID: https://orcid.org/0000-0002-5483-0742)
- Hongcheng Ding (ORCID: https://orcid.org/0000-0002-0745-7607)
- Gaurav Chaudhary (ORCID: https://orcid.org/0000-0003-2167-7443)
- Kun Wang (ORCID: https://orcid.org/0009-0005-4052-6909)
Institutions
- Hubei University of Medicine (CN)
- Novo Nordisk (Denmark) (DK)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Jiangmen Central Hospital (CN)
- Nanjing Jiangning Hospital (CN)
- Novo Nordisk (India) (IN)
- Tianjin Medical University (CN)
- Nanjing Medical University (CN)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1111/dom.16139
- Citations
- 1
- Primary Topic
- Diabetes Management and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.36
Funders
- Novo Nordisk